Eli Lilly has introduced a different method that will permit self-shell out sufferers to purchase the weight-loss drug Zepbound for as tiny as $399 every month—fewer than 50 % the listing price of other incretin medicines utilized for individuals with obesity.Along with the announcement of its new application, Lilly also unveiled an “open lette